www.digi24.ro/stiri/actualitate/dosarele-prin-care

Two cases involving ROMATSA and the Romanian state regarding the seizure of accounts are being heard in Brussels. The claimed amount is 3.42 billion lei plus recovery costs. The decision on the seizure could significantly impact ROMATSA. The cases are linked to a previous execution initiated by Pfizer against the Romanian state. This is the third instance of account blocking for ROMATSA due to state debts, following similar cases in 2015 and 2019. Legal options are being explored to address the current situation, including the possibility of suspending the execution measure.